ZhenDong Pharmaceutical (300158.SZ): The first subject enrolled in Phase IIa clinical trial of the new traditional Chinese medicine class 1.1 drug Xingluo Chengqi Granules.

Zhixin Financial News APP: Zhendong Pharmaceutical (300158.SZ) announced that the company's newly developed Chinese medicine class 1.1 new drug Xingluo Chengqi Granules is currently undergoing phase IIa clinical trials, and the first subject has successfully received the medication recently.